Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 17 Source: Estimated
- €3.2 billion turnover
- 300 employees
-
31st Dec 16 Source: Estimated
- €188.1 million turnover
- 500 employees
- 3 more years available »
Ranking
By Turnover
(€3.2 billion)- 33rd in Top Companies
- 7th in Health
- 6th in Pharma
By Employees
(300)- 469th in Top Companies
- 67th in Health
- 48th in Pharma
- 300
- €3.2 billion
Employees
- Julie O'Neill Senior vice president
Latest News
- 6:48pm Ryanair claims it could lose €5m a year due to ‘peculiar’ Irish tax provision
- 6:44pm Dublin-headquartered Q3 Medical to raise €50m, plans Hong Kong IPO
- 6:35pm European shares lose ground amid concerns over global economic growth
- 6:12pm Man fired over alleged inappropriate remark was reinstated and fired again, court told
- 6:05pm Irish Ferries ‘unlikely’ to operate Rosslare-France route in 2019